Gary A. Ulaner

10.0k total citations
186 papers, 5.1k citations indexed

About

Gary A. Ulaner is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary A. Ulaner has authored 186 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Radiology, Nuclear Medicine and Imaging, 78 papers in Oncology and 59 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary A. Ulaner's work include Medical Imaging Techniques and Applications (58 papers), Radiopharmaceutical Chemistry and Applications (40 papers) and HER2/EGFR in Cancer Research (37 papers). Gary A. Ulaner is often cited by papers focused on Medical Imaging Techniques and Applications (58 papers), Radiopharmaceutical Chemistry and Applications (40 papers) and HER2/EGFR in Cancer Research (37 papers). Gary A. Ulaner collaborates with scholars based in United States, France and Netherlands. Gary A. Ulaner's co-authors include Andrew R. Hoffman, Thanh Vu, Ji‐Fan Hu, Jason S. Lewis, L.C. Giudice, Mithat Gönen, Christopher C. Riedl, Serge K. Lyashchenko, Linda C. Giudice and Debra A. Goldman and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Gary A. Ulaner

175 papers receiving 5.0k citations

Peers

Gary A. Ulaner

RNMI

ONCOL

PHYSI

PRM

Megan L. Troxell United States

Jean‐Frédéric Blanc France

Antonio Gil‐Moreno Spain

Lee K. Tan United States

Charles Zaloudek United States

E.P. Malaise France

Kennedy W. Gilchrist United States

Sylvie Lantuéjoul France

K. Kian Ang United States

Colin A. Purdie United Kingdom

Megan L. Troxell United States

Gary A. Ulaner

556 ×0.3

RNMI

1.5k ×0.9

ONCOL

1.3k ×0.9

202 ×0.2

PHYSI

1.2k ×1.3

PRM

Citations per year, relative to Gary A. Ulaner Gary A. Ulaner (= 1×) peers Megan L. Troxell

Countries citing papers authored by Gary A. Ulaner

Since Specialization

Citations

This map shows the geographic impact of Gary A. Ulaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Ulaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Ulaner more than expected).

Fields of papers citing papers by Gary A. Ulaner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Ulaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Ulaner. The network helps show where Gary A. Ulaner may publish in the future.

Co-authorship network of co-authors of Gary A. Ulaner

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Ulaner. A scholar is included among the top collaborators of Gary A. Ulaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Ulaner. Gary A. Ulaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parihar, Ashwin Singh, et al.. (2025). ¹⁸F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis. Journal of Nuclear Medicine. 66(5). 692–699. 1 indexed citations

Ulaner, Gary A., et al.. (2025). ⁶¹ Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of ⁶¹ Cu-labeled PET Radiotracers. Radiology. 317(3). e251151–e251151.

Groheux, David, Sofia C. Vaz, Lioe‐Fee de Geus‐Oei, et al.. (2025). [ ¹⁸ F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer. Journal of Clinical Oncology. 43(17). 1942–1947.

Yu, Evan Y., Vivek Narayan, Giuseppe Esposito, et al.. (2024). 1604P PSMA-targeted radioligand therapy (RLT) with 131I-LNTH-1095 (1095) plus enzalutamide (enza) vs enza alone in chemotherapy-naïve patients (pts) whose piflufolastat F 18-avid metastatic castration-resistant prostate cancer (mCRPC) progressed on abiraterone (abi): ARROW. Annals of Oncology. 35. S967–S968. 1 indexed citations

Vaz, Sofia C., J.P. Pilkington Woll, Fátima Cardoso, et al.. (2024). Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(9). 2706–2732. 30 indexed citations

Ulaner, Gary A., et al.. (2024). Dotatate PET/CT and ²²⁵Ac-Dotatate Therapy for Somatostatin Receptor–expressing Metastatic Breast Cancer. Radiology. 312(1). e233408–e233408. 6 indexed citations

Groheux, David, Sofia C. Vaz, Philip Poortmans, et al.. (2024). Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines. The Breast. 78. 103806–103806. 2 indexed citations

Ulaner, Gary A., David A. Mankoff, Amy S. Clark, et al.. (2023). Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-¹⁸F-Fluoro-17β-Fluoroestradiol. Journal of Nuclear Medicine. 64(3). 351–354. 46 indexed citations

Chetlen, Alison, Bethany L. Niell, Ann L. Brown, et al.. (2023). ACR Appropriateness Criteria® Breast Implant Evaluation: 2023 Update. Journal of the American College of Radiology. 20(11). S329–S350. 3 indexed citations

10.

Ulaner, Gary A., Jorge A. Carrasquillo, Christopher C. Riedl, et al.. (2020). Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted ⁸⁹Zr-Pertuzumab PET/CT. Radiology. 296(2). 370–378. 45 indexed citations

11.

Ulaner, Gary A. & Ola Landgren. (2020). Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders. Best Practice & Research Clinical Haematology. 33(1). 101148–101148. 10 indexed citations

12.

Henry, Kelly E., Gary A. Ulaner, & Jason S. Lewis. (2018). Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer. PET Clinics. 13(3). 423–435. 21 indexed citations

13.

Wibmer, Andreas G., Hedvig Hricak, Gary A. Ulaner, & Wolfgang Weber. (2018). Trends in oncologic hybrid imaging. SHILAP Revista de lepidopterología. 2(1). 1–1. 23 indexed citations

14.

Ulaner, Gary A., Serge K. Lyashchenko, Christopher C. Riedl, et al.. (2017). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. Journal of Nuclear Medicine. 59(6). 900–906. 141 indexed citations

15.

Ulaner, Gary A., et al.. (2017). 18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 44(9). 1420–1427. 45 indexed citations

16.

Ulaner, Gary A., David M. Hyman, Serge K. Lyashchenko, Jason S. Lewis, & Jorge A. Carrasquillo. (2017). 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2–Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer. Clinical Nuclear Medicine. 42(12). 912–917. 101 indexed citations

17.

Ulaner, Gary A., David M. Hyman, Dara S. Ross, et al.. (2016). Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using ⁸⁹Zr-Trastuzumab PET/CT. Journal of Nuclear Medicine. 57(10). 1523–1528. 144 indexed citations

18.

Ulaner, Gary A., Gabriella D’Andrea, & Hiram S. Cody. (2013). Breast Implant Foreign Body Reaction Mimicking Breast Cancer Recurrence on FDG PET/CT. Clinical Nuclear Medicine. 38(6). 480–481. 13 indexed citations

19.

Hatzoglou, Vaios, Gary A. Ulaner, Zhigang Zhang, et al.. (2012). Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients. Clinical Imaging. 37(3). 451–457. 17 indexed citations

20.

Tao, Li, Thanh Vu, Gary A. Ulaner, et al.. (2005). IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Molecular Human Reproduction. 11(9). 631–640. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact